Implantable device more effective at detecting atrial fibrillation than standard of care

A clinical trial examining the efficacy of two devices to monitor and detect atrial fibrillation (AF), or an irregular heartbeat, in ischemic stroke patients–one an implantable device that monitors over 12 months, the other an external device that monitors over a 30-day period–found the implantable device is more than three times more effective in detecting AF, and both are a significant improvement over the current standard of care in Alberta, Canada.